A measure of striatal function predicts motor stereotypy

Nature Neuroscience

Volumn 3, Issue 4, 2000, Pages 377-383

  Canales, J J ^a,b   Graybiel, A M ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b CENTRO DE INVESTIGACIÓN PRÍNCIPE FELIPE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; APOMORPHINE; COCAINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; NITRIC OXIDE SYNTHASE; PROTEIN C FOS; PROTEIN C JUN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE DEHYDROGENASE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; CELL ACTIVATION; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC TRANSMISSION; GENE INDUCTION; IMMUNOHISTOCHEMISTRY; INTERNEURON; MALE; MOTOR DYSFUNCTION; NONHUMAN; PRIORITY JOURNAL; RAT;

AMPHETAMINE; ANIMALS; APOMORPHINE; CENTRAL NERVOUS SYSTEM STIMULANTS; COCAINE; CORPUS STRIATUM; DOPAMINE AGONISTS; DOPAMINE UPTAKE INHIBITORS; MALE; MOTOR NEURONS; MOVEMENT; PREDICTIVE VALUE OF TESTS; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, SPRAGUE-DAWLEY; STEREOTYPIC MOVEMENT DISORDER;

EID: 0034069631     PISSN: 10976256     EISSN: None     Source Type: Journal    
DOI: 10.1038/73949     Document Type: Article

References (50)

1. Ridley, R. M. The psychology of perseverative and stereotyped behaviour. Prog. Neurobiol. 44, 221-231 (1994).
2. Manschreck, T. C. in Handbook of Schizophrenia Vol. 1. The Neurology of Schizophrenia (eds. Nasrallah, H. A. & Weinberger, D. R.) 65-96 (Elsevier, Amsterdam, 1986).
3. Antony, M. M., Downie, F. & Swinson, R. P. in Obsessive-compulsive Disorder: Theory, Research and Treatment (eds. Swinson, R. P., Antony, M. M., Rachman, S. & Richter, M. A.) 3-32 (Guildford, Oxford, 1988).
4. Randrup, A. & Munkvad, I. Influence of amphetamines on animal behaviour: stereotypy, functional impairment and possible animal-human correlations. Psychiatr. Neurol. Neurochir. 75, 193-202 (1972).
5. Gold, L. H., Geyer, M. A. & Koob, G. F. Neurochemical mechanisms involved in behavioral effects of amphetamines and related designer drugs. NIDA Res. Monogr. 94, 101-126 (1989).
6. Fog, R. On stereotypy and catalepsy: studies on the effect of amphetamines and neuroleptics in rats. Acta Neurol. Scand. Suppl. 50, 3-66 (1972).
7. Costall, B. & Naylor, R. J. Dissociation of stereotyped biting responses and oro-bucco-lingual dyskinesias. Eur. J. Pharmacol. 36, 423-429 (1976).
8. Creese, I. & Iversen, S. D. Amphetamine response in rat after dopamine neurone destruction. Nat. New Biol. 238, 247-248 (1972).
9. Fibiger, H. C., Fibiger, H. P. & Zis, A. P. Attenuation of amphetamine-induced motor stimulation and stereotypy by 6-hydroxydopamine in the rat. Br. J. Pharmacol. 47, 683-692 (1973).
10. Arnt, J. Antistereotypic effects of dopamine D-1 and D-2 antagonists after intrastriatal injection in rats. Pharmacological and regional specificity. Naunyn Schmiedebergs Arch. Pharmacol. 330, 97-104 (1985).
11. Cummings, J. L. Anatomic and behavioral aspects of frontal-subcortical circuits. Ann. NY Acad. Sci. 769, 1-13 (1995).
12. Rosenberg, D. R., Dick, E. L., O'Hearn, K. M. & Sweeney, J. A. Response-inhibition deficits in obsessive-compulsive disorder: an indicator of dysfunction in frontostriatal circuits. J. Psychiatry Neurosci. 22, 29-38 (1997).
13. Graybiel, A. M. The basal ganglia and cognitive pattern generators. Schizophr. Bull. 23, 459-469 (1997).
14. Graybiel, A. M., Moratalla, R. & Robertson, H. A. Amphetamine and cocaine induce drug-specific activation of the c-fos gene in striosome-matrix compartments and limbic subdivisions of the striatum. Proc. Natl. Acad. Sci. USA 87, 6912-6916 (1990).
15. Curran, T. & Morgan, J. I. Fos: an immediate-early transcription factor in neurons. J. Neurobiol. 26, 403-412 (1995).
16. Sharp, F. R., Sagar, S. M. & Swanson, R. A. Metabolic mapping with cellular resolution: c-fos vs. 2-deoxyglucose. Crit. Rev. Neurobiol. 7, 205-228 (1993).
17. Pierce, R. C. & Kalivas, P. W. A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res. Brain Res. Rev. 25, 192-216 (1997).
18. Segal, D. S., Weinberger, S. B., Cahill, J. & McCunney, S. J. Multiple daily amphetamine administration: behavioral and neurochemical alterations. Science 207, 905-907 (1980).
19. Hope, B. T. et al. Induction of long-lasting AP-1 complex composed of altered Fos-like proteins in brain by chronic cocaine and other chronic treatments. Neuron 13, 1235-1244 (1994).
20. Rosen, J. B., Chuang, E. & Iadarola, M. J. Differential induction of Fos protein and a Fos-related antigen following acute and repeated cocaine administration. Mol. Brain Res. 25, 168-172 (1994).
21. Moratalla, R., Elibol, B., Vallejo, M. & Graybiel, A. M. Network-level changes in expression of inducible Fos-Jun proteins in the striatum during chronic cocaine treatment and withdrawal. Neuron 17, 147-156 (1996).
22. Scheel-Kruger, J. Behavioural and biochemical comparison of amphetamine derivatives, cocaine, benztropine and tricyclic anti-depressant drugs. Eur. J. Pharmacol. 18, 63-73 (1972).
23. Bhat, R. V., Cole, A. J. & Baraban, J. M. Role of monoamine systems in activation of zif268 by cocaine. J. Psychiatry Neurosci. 17, 94-102 (1992).
24. Ramamoorthy, S. & Blakely, R. D. Phosphorylation and sequestration of serotonin transporters differentially modulated by psychostimulants. Science 285, 763-766 (1999).
25. Steiner, H. & Gerfen, C. R. Role of dynorphin and enkephalin in the regulation of striatal output pathways and behavior. Exp. Brain Res. 123, 60-76 (1998).
26. Wang, J. Q., Daunais, J. B. & McGinty, J. F. NMDA receptors mediate amphetamine-induced upregulation of zif/268 and preprodynorphin mRNA expression in rat striatum. Synapse 18, 343-353 (1994).
27. Aosaki, T., Kimura, M. & Graybiel, A. M. Temporal and spatial characteristics of tonically active neurons of the primate's striatum. J. Neurophysiol. 73, 1234-1252 (1995).
28. Calabresi, P. et al. A critical role of the nitric oxide/cGMP pathway in corticostriatal long-term depression. J. Neurosci. 19, 2489-2499 (1999).
29. Wang, J. Q. & McGinty, J. F. Alterations in striatal zif/268, preprodynorphin and preproenkephalin mRNA expression induced by repeated amphetamine administration in rats. Brain Res. 673, 262-274 (1995).
30. Konradi, C., Leveque, J.-C. & Hyman, S. E. Amphetamine and dopamine-induced immediate early gene expression in striatal neurons depends on postsynaptic NMDA receptors and calcium. J. Neurosci. 16, 4231-4239 (1996).
31. Torres, G. & Rivier, C. Cocaine-induced expression of striatal c-fos in the rat is inhibited by NMDA receptor antagonists. Brain Res. Bull. 30, 173-176 (1993).
32. 2+- and stimulus duration-dependent switch for hippocampal gene expression. Cell 87, 1203-1214 (1996).
33. Liu, F.-C. & Graybiel, A. M. Spatiotemporal dynamics of CREB phosphorylation: Transient versus sustained phosphorylation in the developing striatum. Neuron 17, 1133-1144 (1996).
34. Dragunow, M. A role for immediate-early transcription factors in learning and memory. Behav. Genet. 26, 293-299 (1996).
35. Mello, C. V. & Clayton, D. F. Song-induced ZENK gene expression in auditory pathways of songbird brain and its relation to the song control system. J. Neurosci. 14, 6652-6666 (1994).
36. Graybiel, A. M. Neurotransmitters and neuromodulators in the basal ganglia. Trends Neurosci. 13, 244-254 (1990).
37. Gerfen, C. R. The neostriatal mosaic: multiple levels of compartmental organization. Trends Neurosci. 15, 133-139 (1992).
38. Volkow, N. D., Fowler, J. S., Wolf, A. P. & Gillespie, H. Metabolic studies of drugs of abuse. NIDA Res. Monogr. 105, 47-53 (1991).
39. Robbins, T. Stereotypies: addictions or fragmented actions? Bull. Br. Psychol. Soc. 35, 297-300 (1982).
40. Lyon, M. & Robbins, T. W. in Current Developments in Psychopharmacology (eds. Essmann, W. B. & Valzelli, L.) 80-163 (Spectrum, New York, 1975).
41. LaHoste, G. J. & Marshall, J. F. The role of dopamine in the maintenance and breakdown of D1/D2 synergism. Brain Res. 611, 108-116 (1993).
42. Paul, M. L., Graybiel, A. M., David, J.-C. & Robertson, H. A. D1-like and D2-like dopamine receptors synergistically activate rotation and c-fos expression in the dopamine-depleted striatum in a rat model of Parkinson's disease. J. Neurosci. 12, 3729-3742 (1992).
43. Wirtshafter, D. & Asin, K. E. Interactive effects of stimulation of D1 and D2 dopamine receptors on fos-like immunoreactivity in the normosensitive rat striatum. Brain Res. Bull. 35, 85-91 (1994).
44. Xu, M. et al. Elimination of cocaine-induced hyperactivity and dopamine-mediated neurophysiological effects in dopamine D1 receptor mutant mice. Cell 79, 945-955 (1994).
45. Xu, M. et al. Dopamine D1 receptor mutant mice are deficient in striatal expression of dynorphin and in dopamine-mediated behavioral responses. Cell 79, 729-742 (1994).
46. Arnt, J. Antistereotypic effects of dopamine D-1 and D-2 antagonists after intrastriatal injection in rats. Pharmacological and regional specificity. Naunyn Schmiedebergs Arch. Pharmacol. 330, 97-104 (1985).
47. Hiroi, N. & Graybiel, A. M. Atypical and typical neuroleptic treatments induce distinct programs of transcription factor expression in the striatum. J. Comp. Neurol. 374, 70-83 (1996).
48. Hughes, P. & Dragunow, M. Induction of immediate-early genes and the control of neurotransmitter-regulated gene expression within the nervous system. Pharmacol. Rev. 47, 133-178 (1995).
49. Albin, R. L., Young, A. B. & Penney, J. B. The functional anatomy of basal ganglia disorders. Trends Neurosci. 12, 366-375 (1989).
50. Wichmann, T. & DeLong, M. R. Models of basal ganglia function and pathophysiology of movement disorders. Neurosurg. Clin. N. Am. 9